434 related articles for article (PubMed ID: 9382667)
1. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
[TBL] [Abstract][Full Text] [Related]
2. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
3. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
5. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in critical illness.
Dentali F; Crowther M
Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
[TBL] [Abstract][Full Text] [Related]
8. How much warfarin is enough in APS related thrombosis?
Erkan D; Lockshin MD
Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
[TBL] [Abstract][Full Text] [Related]
9. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
11. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Crowther MA; Wisloff F
Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
[TBL] [Abstract][Full Text] [Related]
12. Management of the neurological manifestations of APS--what do the trials tell us?
Brey RL
Thromb Res; 2004; 114(5-6):489-99. PubMed ID: 15507283
[TBL] [Abstract][Full Text] [Related]
13. The Italian Registry of Antiphospholipid Antibodies.
Finazzi G
Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
15. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
16. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
Brunner HI; Chan WS; Ginsberg JS; Feldman BM
J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
[TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
19. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]